HN019 fermentation product
A fermentation product of Bifidobacterium animalis subsp. lactis HN019 addresses decreased antioxidant and metabolic health issues by enhancing immune and cellular function, reducing disease risk, and managing weight through specific compositions.
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- FONTERRA COOP GRP LTD
- Filing Date
- 2025-11-25
- Publication Date
- 2026-06-04
AI Technical Summary
There is a need to maintain or increase antioxidant status and metabolic health in individuals facing challenges from environmental pollution, inflammation, smoking, alcohol use, UV exposure, mental stress, and aging, which can lead to reduced immune health, cellular health, skin health, vitality, and increased risk of diseases like type 2 diabetes and obesity.
Administration of a composition comprising a fermentation product of Bifidobacterium animalis subsp. lactis HN019 or its parts/derivatives, which includes culturing and inactivating live cells to produce a fermentation product with reduced cfu/g, for use in pharmaceutical, nutraceutical, or nutritional compositions.
The fermentation product enhances antioxidant status and metabolic health by reducing ROS, improving immune and cellular health, reducing signs of aging, fatigue, and the risk of diseases such as type 2 diabetes, while managing weight and blood glucose levels.
Smart Images

Figure IMGF000065_0001 
Figure IMGF000065_0002 
Figure IMGF000066_0001